Premium
IC‐P‐059: Assessment of Aβ Deposition in Mild Cognitive Impairment with 18F‐Florbetaben
Author(s) -
Ong Kevin,
Villemagne Victor L.,
Langdon Narelle,
Holl Gerhard,
Reininger Cornelia,
Putz Barbara,
Jones Gareth,
Mulligan Rachel,
Pejoska Svetlana,
Rohde Beate,
Masters Colin L.,
Rowe Christopher C.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.074
Subject(s) - neuropathology , cognitive impairment , pittsburgh compound b , medicine , standardized uptake value , cognitive decline , nuclear medicine , cardiology , psychology , positron emission tomography , disease , dementia
IC-P-059 ASSESSMENT OF Ab DEPOSITION IN MILD COGNITIVE IMPAIRMENT WITH 18FFLORBETABEN Kevin Ong, Victor L. Villemagne, Narelle Langdon, Gerhard Holl, Cornelia Reininger, Barbara Putz, Gareth Jones, Rachel Mulligan, Svetlana Pejoska, Beate Rohde, Colin L. Masters, Christopher C. Rowe, Austin Hospital, Melbourne, VIC, Australia; The Mental Health Research Institute, Melbourne, VIC, Australia; Bayer Schering Pharma, Berlin, Germany. Contact e-mail: kevin.ong@petnm.unimelb.edu.au